Group 1 - Xianle Health's stock price fell by 1.45% on January 12, closing at 24.39 CNY per share, with a trading volume of 176 million CNY and a turnover rate of 2.80%, resulting in a total market capitalization of 7.503 billion CNY [1] - The stock has experienced a continuous decline for six days, with a cumulative drop of 5.68% during this period [1] - Xianle Health, established on August 16, 1993, and listed on September 25, 2019, specializes in the research, production, sales, and technical services of nutritional health products [1] Group 2 - The main revenue composition of Xianle Health includes soft capsules (46.38%), gummies (25.31%), tablets (9.26%), beverages (5.42%), hard capsules (5.31%), powders (4.45%), and other forms (3.22%), with additional supplements accounting for 0.65% [1] - Among the top ten circulating shareholders, the Everbright Prudential Credit Enhancer Bond A Fund (360013) entered the list in the third quarter, holding 2.0329 million shares, which is 0.79% of the circulating shares [2] - The fund has incurred a floating loss of approximately 731,800 CNY today and a total floating loss of 2.9884 million CNY during the six-day decline [2]
仙乐健康股价连续6天下跌累计跌幅5.68%,光大保德信基金旗下1只基金持203.29万股,浮亏损失298.84万元